Viveve Medical, Inc. VIVE

Full chart Compare
Set alert

Price alert · VIVE

All alert types
0.00 USD 0.00 (+0.00%)

At closeNov 2, 2026, 4:00 PM EST

0.0001 Day range 0.0001
0.0001 52-week range 0.001
YTD
+100.00%
1 year
+100.00%

Analyst view

Consensus: buy

Buy
Price target (mean) 3.10
Ratings (0m) 6 6 buy · 0 hold · 0 sell
  • Strong buy1
  • Buy5
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 6
  • 1 month ago 2
  • 2 months ago 2
  • 3 months ago 5

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

VIVE analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.62-0.62 – -0.62-0.72+13.9%1.77M+3.8%1
Next quarter-0.47-0.47 – -0.47-0.67+29.9%2.13M+29.8%1
Current year-2.55-2.55 – -2.55-2.65+3.8%6.89M+7.2%1
Next year-1.60-1.60 – -1.60-2.55+37.3%11.14M+61.7%1

Upgrades and downgrades

The latest rating changes

VIVE analyst upgrades and downgrades
DateFirmActionFromTo
Nov 25, 2020Ladenburg ThalmannUpgradeNeutralBuy
Nov 25, 2020Ladenburg ThalmannDowngradeBuyNeutral
Nov 25, 2020Maxim GroupDowngradeBuyHold
Nov 25, 2020MizuhoDowngradeBuyUnderperform
Nov 25, 2020Mizuho SecuritiesDowngradeBuyUnderperform
Nov 25, 2020Stifel NicolausDowngradeBuyHold
Nov 25, 2020Raymond JamesDowngradeOutperformMarket Perform
Nov 25, 2020Raymond JamesMaintainedOutperformOutperform
Nov 25, 2020Stifel NicolausInitiated—Buy
Nov 25, 2020Empire Asset ManagementInitiated—Buy
Nov 25, 2020Northland SecuritiesInitiated—Outperform
Nov 25, 2020MizuhoInitiated—Buy
Nov 25, 2020Raymond JamesInitiated—Outperform
Nov 25, 2020Cowen & Co.Initiated—Outperform
Nov 25, 2020B. Riley FBRInitiated—Buy
Nov 25, 2020Ladenburg ThalmannInitiated—Buy